sulpiride has been researched along with Eye Cancer, Retinoblastoma in 1 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dopamine dose-response curve for inducing desensitization exhibits an EC50 of approximately 2-3 microM and a maximal response at approximately 0." | 1.28 | Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells. ( Barton, AC; Black, LE; Sibley, DR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, AC | 1 |
| Black, LE | 1 |
| Sibley, DR | 1 |
1 other study available for sulpiride and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Cell Differentiation; Dopamine; Dopamine Agent | 1991 |